CN106749194B - A kind of preparation method for pyrimidine - Google Patents

A kind of preparation method for pyrimidine Download PDF

Info

Publication number
CN106749194B
CN106749194B CN201710058262.7A CN201710058262A CN106749194B CN 106749194 B CN106749194 B CN 106749194B CN 201710058262 A CN201710058262 A CN 201710058262A CN 106749194 B CN106749194 B CN 106749194B
Authority
CN
China
Prior art keywords
reaction
pyrimidine
chloro
chloromethyluracil
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201710058262.7A
Other languages
Chinese (zh)
Other versions
CN106749194A (en
Inventor
高大龙
杨庆坤
周学文
李保勇
吴柯
张兆珍
董廷华
杨波勇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong Anxin Pharmaceutical Co., Ltd
Original Assignee
Qilu Tianhe Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qilu Tianhe Pharmaceutical Co Ltd filed Critical Qilu Tianhe Pharmaceutical Co Ltd
Priority to CN201710058262.7A priority Critical patent/CN106749194B/en
Publication of CN106749194A publication Critical patent/CN106749194A/en
Application granted granted Critical
Publication of CN106749194B publication Critical patent/CN106749194B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Abstract

The invention discloses a kind of preparation methods for pyrimidine.This method first passes through chlorination and obtains intermediate A using 6- chloromethyluracil as starting material, then carries out condensation reaction with alpha-pyrrolidone in the presence of highly basic and improves the selectivity reacted, last intermediate B is obtained through ammonolysis reaction for pyrimidine.The preparation method is simple, and reaction condition is mild, the purity is high of product, high income, is suitable for industrialized production.

Description

A kind of preparation method for pyrimidine
Technical field
The invention belongs to pharmaceutical technology field, more specifically to a kind of preparation method for pyrimidine.
Background technique
It is one of the main component of fluorine glycosides pyrimidine piece that hydrochloric acid, which replaces a pyrimidine (TPI), and fluorine glycosides pyrimidine piece is Japanese roc medicine A kind of compound preparation of product Industrial Co., Ltd exploitation, 03 month 2014 medicine are ratified to control for standard scheme by Japanese PMDA Treat invalid unresectable advanced stage or recurrent colorectal cancer.Component in fluorine glycosides pyrimidine piece contains hydrochloric acid for pyrimidine (TPI), hydrochloric acid is then able to suppress the thymidine phosphorylase for participating in degradation trifluorothymidine for pyrimidine, to maintain having for trifluorothymidine Imitate blood concentration.It is able to suppress the adverse reaction of trifluorothymidine independent medication simultaneously, to enhance drug safety.Hydrochloric acid for The structural formula of pyrimidine is as follows.
Currently, replacing the primary synthetic methods (such as EP1080726A1 patent) of a pyrimidine are as follows: be with 6- (chloromethyl) uracil Starting material, first react with sulfonic acid chloride generation the chloro- 6- chloromethyluracil of 5-, then using sodium ethoxide as acid binding agent, in DMF and 2- imido grpup pyrrolidines reacts to obtain for pyrimidine.Chemical equation is as follows:
In above-mentioned synthetic method, impurity is more in reaction solution, and purification is relatively difficult, and the yield of product is not high, yield About 35% or so.
Summary of the invention
For the problem that preparation is low for yield present in pyrimidine in existing industrial production, purity difference, the present invention is mentioned A kind of preparation method for pyrimidine is supplied.This method first passes through chlorination and obtains using 6- chloromethyluracil as starting material To intermediate A, condensation reaction then is carried out with alpha-pyrrolidone in the presence of highly basic and improves the selectivity reacted, it is last intermediate Body B is obtained through ammonolysis reaction for pyrimidine.The preparation method is simple, and reaction condition is mild, the purity is high of product, high income, fits Suitable industrialized production.
The technical scheme is that a kind of preparation method for pyrimidine, characterized in that
1) using 6- chloromethyluracil as starting material, it is chloro- that 5- is obtained with N- chlorosuccinimide progress chlorination 6- chloromethyluracil (intermediate A);
2) then in the presence of highly basic, intermediate A and alpha-pyrrolidone carry out condensation reaction and obtain 5- chloro- 6- (2- carbonyl Pyrrolidinyl -1- base) methyl -2,4- (1H, 3H) hybar X (intermediate B);
3) intermediate B and ammonium hydroxide generation ammonolysis reaction obtain for pyrimidine.
Reaction equation is as follows.
Preferably, the reaction dissolvent of step 1) be dimethyl sulfoxide, acetonitrile, methanol or n,N-Dimethylformamide, it is more excellent Select dimethyl sulfoxide;
Preferably, the molar ratio of step 1) 6- chloromethyluracil and N- chlorosuccinimide is 1:2.0~3.0.
Preferably, step 1) reaction temperature is 50~70 DEG C, and the reaction time is 2~4h.
Preferably, step 2) reaction dissolvent is tetrahydrofuran, methylene chloride, methanol, n,N-Dimethylformamide, preferably four Hydrogen furans.
Preferably, highly basic used in step 2) is n-BuLi, sodium hydride or lithium diisopropyl amido, more preferable positive fourth Base lithium.
Preferably, the molar ratio of step 2) intermediate A, alpha-pyrrolidone and highly basic is 1:1.4~1.6:1.4~1.6.
Preferably, step 2) reaction temperature is 0~10 DEG C, and the reaction time is 2~4h.
Preferably, the solvent of step 3) reaction is toluene, tetrahydrofuran or DMF, preferably DMF.
Preferably, step 3) intermediate B and concentrated ammonia liquor molar ratio are 1:1.4~1.6.
Preferably, step 3) reaction temperature is 80~90 DEG C, and the reaction time is 2~3h.
It is of the invention specific steps are as follows:
1) 6- chloromethyluracil is added in reaction dissolvent, adds N- chlorosuccinimide, then heats to 50 ~70 DEG C of 2~4h of insulation reaction;After completion of the reaction, reaction solution is poured into water and yellow solid is precipitated, then filtered, dried Obtain intermediate A;
2) alpha-pyrrolidone is slowly dropped in n-butyllithium solution, reacts at 0~5 DEG C of temperature control, is dripped after fully reacting It is added in the solution of intermediate A and carries out 2~4h of reaction for 0~10 DEG C of temperature control;After being filtered after the reaction was completed, adding water mashing and drying Obtain intermediate B;
3) intermediate B is added in organic solvent, concentrated ammonia liquor is then added and reacts 2~3h at 80~90 DEG C, has reacted Cheng Houjia elutriation goes out solid, is filtered, dries to obtain for pyrimidine.
The beneficial effects of the present invention are:
1, the present invention avoids, labile sulphonyl strong using corrosivity using N- chlorosuccinimide as chlorinating agent Chlorine reduces risk.Reactive intermediate first is generated with alpha-pyrrolidone using highly basic such as n-BuLis in condensation reaction simultaneously Then it is reacted again with intermediate A, further improves the selectivity of condensation reaction, keep the yield 90% of condensation reaction left It is right;
2, the preparation method is simple, and reaction condition is mild, the purity is high (>=99.8%) of product, high income (>=75%), It is suitable for industrialized production.
Specific embodiment
Embodiment 1
1) 6- chloromethyluracil 10.0g is dissolved in 100ml dimethyl sulfoxide, is added under stirring condition at room temperature 17.0g chlorosuccinimide finishes and is warming up to 60 DEG C, and carries out insulation reaction 4h.The system of reaction is added to 400ml water Middle precipitation light yellow solid filters, obtains 11.0g intermediate A, yield 90.7% after drying.
2) n-BuLi hexane solution (2mol/L) 33.6ml is added in reaction flask, 50ml tetrahydrofuran is added, it will Alpha-pyrrolidone 5.9g is slowly dropped in reaction flask, is controlled 0-5 DEG C of temperature reaction, is added drop-wise among 9.0g after complete reaction In the 50ml tetrahydrofuran solution of body A, then temperature control carries out reaction 3h to 5 DEG C, is warming up to room temperature after reaction, filters, Gu Body object adds water mashing washing, filters, obtains 10.2g intermediate B, yield 90.2% after drying.
3) intermediate B 7.0g is weighed, 50ml DMF is added, is added 2.6g concentrated ammonia liquor (concentration 28%), is warming up to 85 DEG C instead 2h is answered, reaction terminates to be down to room temperature, and 100ml elutriation is added and goes out solid, filters, obtains solid 6.4g, yield 91.8% after drying; Total yield of products is 75.1%, and the purity of product is 99.87%.
Embodiment 2
1) 6- chloromethyluracil 10.0g is dissolved in 100ml n,N-Dimethylformamide, at room temperature under stirring condition 16.5g chlorosuccinimide is added, finishes and is warming up to 60 DEG C, and carry out insulation reaction 3h.The system of reaction is added to Light yellow solid is precipitated in 400ml water, filters, obtain 11.4g intermediate A, yield 94.0% after drying.
2) lithium diisopropyl amido THF solution (2.0mol/L) 37.5ml is added in reaction flask, 50ml methanol is added, it will Alpha-pyrrolidone 6.6g is slowly dropped in reaction flask, is controlled 0-5 DEG C of temperature reaction, is added drop-wise among 10g after complete reaction In the methanol solution of body A, then temperature control carries out reaction 3h to 0 DEG C, is warming up to room temperature after reaction, filters, and water is added to be beaten water Wash, filter, dry after obtain 11.3g intermediate B, yield 90.0%.
3) intermediate B 7.0g is weighed, 50mlDMF is added, is added 2.7g concentrated ammonia liquor (28% concentration), is warming up to 85 DEG C of reactions 3h, reaction terminate to be down to room temperature, and 100ml elutriation is added and goes out solid, filters, solid 6.5g, yield 93.2% is obtained after drying;It produces Product purity is 99.89%, total yield of products 78.8%.
Embodiment 3
1) 6- chloromethyluracil 10.0g is dissolved in 100mlN, in dinethylformamide, at room temperature under stirring condition plus Enter 16.8g chlorosuccinimide, finishes and be warming up to 60 DEG C, and carry out insulation reaction 4h.The system of reaction is added to 400ml Light yellow solid is precipitated in water, filters, obtain 11.2g intermediate A, yield 92.3% after drying.
2) n-BuLi hexane solution (2mol/L) 38.2ml is added in reaction flask, 50ml methanol is added, by α-pyrrole Pyrrolidone 6.5g is slowly dropped in reaction flask, is controlled 0-5 DEG C of temperature reaction, is added drop-wise to 10g intermediate A after complete reaction In methanol solution, then temperature control carries out reaction 2h to 0 DEG C, is warming up to room temperature after reaction, filters, and adds water mashing washing, takes out 11.2g intermediate B, yield 89.2% are obtained after filter, drying.
3) intermediate B 7.0g is weighed, 50ml DMF is added, is added 2.6g concentrated ammonia liquor (concentration 28%), is warming up to 85 DEG C instead 3h is answered, reaction terminates to be down to room temperature, and 100ml elutriation is added and goes out solid, filters, solid 6.6g, yield 94.6% is obtained after drying; Product purity is 99.92%, total yield of products 77.8%.
Comparative example (referring to EP1080726A1 patent)
1) under room temperature by 12ml sulfonic acid chloride be slowly added dropwise acetic acid (50mL) 6- chloromethyluracil (16.3g) it is outstanding In turbid, 3h is stirred at room temperature, reaction solution is added in ice water (50ml), stirring, crystallization, suction filtration obtain the chloro- 6- of solid 5- Chloromethyluracil (18.2g), yield 92%;
2) the chloro- 6- chloromethyluracil (5.0g) of 5-, 2- imido grpup pyrrolidines (6.14g), sodium ethoxide (5.24g) are added to In 50ml DMF solution, 14h is stirred under room temperature, is filtered, and solid is added in 30ml water, is carried out after being neutralized with acetic acid Washing filters.Active carbon is added after the dissolving with hydrochloric acid that the solid being obtained by filtration passes through 1N, filters.Filtrate decompression obtains solid 2.68g, yield 38.2%;Total recovery is 35.1%;Purity is 98.7%.

Claims (7)

1. a kind of preparation method for pyrimidine, characterized in that the following steps are included:
1) using 6- chloromethyluracil as starting material, chlorination is carried out with N- chlorosuccinimide and obtains the chloro- 6- chlorine of 5- Methyluracil;
2) then in the presence of highly basic, the chloro- 6- chloromethyluracil of 5- and alpha-pyrrolidone carry out condensation reaction and obtain the chloro- 6- of 5- (2- carbonyl pyrrolidine alkyl -1- base) methyl -2,4- (1H, 3H) hybar X;Highly basic used be n-BuLi, sodium hydride or Lithium diisopropyl amido;
3) then ammonolysis occurs for the chloro- 6- of 5- (2- carbonyl pyrrolidine alkyl -1- base) methyl -2,4- (1H, 3H) hybar X and ammonium hydroxide Reaction obtains for pyrimidine.
2. a kind of preparation method for pyrimidine as described in claim 1, characterized in that highly basic used in step 2) is positive fourth Base lithium.
3. a kind of preparation method for pyrimidine as claimed in claim 2, characterized in that the following steps are included:
1) 6- chloromethyluracil is added in reaction dissolvent, adds N- chlorosuccinimide, then heats to 50~70 DEG C 2~4h of insulation reaction;After completion of the reaction, reaction solution is poured into water and yellow solid is precipitated, then filtered, dry to obtain The chloro- 6- chloromethyluracil of 5-;
2) alpha-pyrrolidone is added drop-wise in n-butyllithium solution, is reacted at 0~5 DEG C of temperature control, it is chloro- that 5- is added drop-wise to after fully reacting 2~4h of reaction is carried out for 0~10 DEG C of temperature control in the solution of 6- chloromethyluracil;It is filtered after the reaction was completed plus water is beaten and dries The chloro- 6- of 5- (2- carbonyl pyrrolidine alkyl -1- base) methyl -2,4- (1H, 3H) hybar X is obtained after dry;
3) step 2) product is added in organic solvent, concentrated ammonia liquor is then added and reacts 2~3h at 80~90 DEG C, reaction is completed Afterwards plus elutriation goes out solid, is filtered, dries to obtain for pyrimidine;The mass concentration of the concentrated ammonia liquor is 28%.
4. a kind of preparation method for pyrimidine as claimed in claim 3, characterized in that the reaction dissolvent of the step 1) is Dimethyl sulfoxide, acetonitrile, methanol or N,N-dimethylformamide.
5. a kind of preparation method for pyrimidine as described in any one of claim 1-3, characterized in that 6- in step 1) The molar ratio of chloromethyluracil and N- chlorosuccinimide is 1:2.0~3.0.
6. a kind of preparation method for pyrimidine as described in any one of claim 1-3, characterized in that 5- in step 2) The molar ratio of chloro- 6- chloromethyluracil, alpha-pyrrolidone and highly basic is 1:1.4~1.6:1.4~1.6.
7. a kind of preparation method for pyrimidine as claimed in claim 3, characterized in that the chloro- 6- of 5- (2- carbonyl in step 3) Pyrrolidinyl -1- base) methyl -2,4- (1H, 3H) hybar X and concentrated ammonia liquor molar ratio be 1:1.4~1.6.
CN201710058262.7A 2017-01-23 2017-01-23 A kind of preparation method for pyrimidine Active CN106749194B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710058262.7A CN106749194B (en) 2017-01-23 2017-01-23 A kind of preparation method for pyrimidine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710058262.7A CN106749194B (en) 2017-01-23 2017-01-23 A kind of preparation method for pyrimidine

Publications (2)

Publication Number Publication Date
CN106749194A CN106749194A (en) 2017-05-31
CN106749194B true CN106749194B (en) 2019-05-07

Family

ID=58942106

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710058262.7A Active CN106749194B (en) 2017-01-23 2017-01-23 A kind of preparation method for pyrimidine

Country Status (1)

Country Link
CN (1) CN106749194B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3681880A4 (en) * 2017-09-14 2021-06-23 Aurobindo Pharma Limited Process for preparing crystalline tipiracil hydrochloride
US10866219B2 (en) * 2017-12-22 2020-12-15 Taiho Pharmaceutical Co., Ltd. Method for detecting trifluridine- and/or tipiracil-related substance
EP3730935A4 (en) 2017-12-22 2022-02-23 Taiho Pharmaceutical Co., Ltd. Method for detecting trifluridine- and/or tipiracil-derived analogs
US10816517B2 (en) 2018-01-05 2020-10-27 Taiho Pharmaceutical Co., Ltd. Method for detecting trifluridine-related substance by high-performance liquid chromatography
WO2019135405A1 (en) 2018-01-05 2019-07-11 大鵬薬品工業株式会社 Detection method for analog derived from trifluridine
CN109796441B (en) * 2019-02-19 2020-10-16 北京民康百草医药科技有限公司 Preparation method of impurity A of tipyrimidine hydrochloride
CN109776429A (en) * 2019-03-11 2019-05-21 河南湾流生物科技有限公司 A kind of Pyrimdinone molecule and its preparation method and application for promoting SOD vigor in cosmetics
CN112028837A (en) * 2019-06-03 2020-12-04 鲁南制药集团股份有限公司 Tilpyrimidine intermediate compound

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1407854A (en) * 1999-12-03 2003-04-02 拜尔公司 N-aryi-uracile-based herbicides
CN105859691A (en) * 2016-04-07 2016-08-17 扬子江药业集团南京海陵药业有限公司 Novel crystal form of thymidine phosphorylase inhibitor and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1407854A (en) * 1999-12-03 2003-04-02 拜尔公司 N-aryi-uracile-based herbicides
CN105859691A (en) * 2016-04-07 2016-08-17 扬子江药业集团南京海陵药业有限公司 Novel crystal form of thymidine phosphorylase inhibitor and preparation method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Metal free stereoselective synthesis of functionalized Enamides;Lone, Ali Mohd; Bhat, Bilal Ahmad;《Organic & Biomolecular Chemistry》;20141231;第12卷(第2期);242-246
Pyrimidine derivatives. V. Synthesis and nucleophilic reactions of 5-bromo-6-bromomethyl-1-(2-bromoethyl and 2-bromopropyl)-3-methyl-2,4(1H,3H)-pyrimidinedione;Kinoshita, Toshio等;《Chemical & Pharmaceutical Bulletin》;19881231;第36卷(第10期);3887-96
Reaction of o-phenylenediamine with acetoacetic and a-chloroacetoacetic esters;Sheremet, V. I.等;《Khimiya Geterotsiklicheskikh Soedinenii》;19811231(第9期);1255-9

Also Published As

Publication number Publication date
CN106749194A (en) 2017-05-31

Similar Documents

Publication Publication Date Title
CN106749194B (en) A kind of preparation method for pyrimidine
CN102985416B (en) Process of preparing a thrombin specific inhibitor
CN104945299B (en) A kind of high-efficiency synthesis method of vildagliptin
CN106279104A (en) A kind of process modification method preparing succinum love song Ge Lieting
CN103408548B (en) The method of synthesis (R)-9-(2-hydroxypropyl) VITAMIN B4
CN101914064B (en) Method for preparing sulfachlororyridazine sodium
CN104262326A (en) Preparation method of pantoprazole sodium
CN106008459B (en) The preparation method of one koji Ge Lieting
CN105039466B (en) A kind of preparation method of Vidarabine Monophosphate
US8637669B2 (en) Production method for adefovir dipivoxil
CN104418793B (en) The preparation method of anti-azheimer's disease drug Lu-AE-58054
CN103254156B (en) Ah method is for the preparation method of Buddhist nun's intermediate
CN103408487B (en) Refining method of gimeracil
CN112661707B (en) Preparation method of dacomitinib
CN108484508A (en) A kind of synthetic method of 5- trifluoromethyl uracils
CN108794479A (en) A kind of synthetic method of 4- chloropyrrolo [2,3-ds
CN103588712A (en) Pyrimidine compound and preparation method and application thereof
CN109942633B (en) Preparation method of tenofovir alafenamide intermediate
CN108117523B (en) Preparation method of halogenated uracil compound
CN111303045A (en) Production process of 2-ethoxy-4, 6-difluoropyrimidine
CN107759618B (en) Preparation method of brinzolamide and intermediate thereof
CN105461690B (en) The preparation method of high-purity ((5- (2- fluorophenyls) -1- (pyridin-3-yl sulfonyl) -1H- pyrroles -3- bases) methyl) (methyl) t-butyl carbamate
CN109053590A (en) A method of preparing the chloro- 2- aminopyrimidine of 4,6- bis-
CN110016029A (en) A kind of preparation method of fluoro- 1H- pyrrolo- [2,3-b] pyridine-2-carboxylic acids of 3-
CN105399688A (en) Gefitinib preparation method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20200226

Address after: No. 10678, Wenliang Road, Dongjia street, Licheng District, Jinan City, Shandong Province

Patentee after: Shandong Anxin Pharmaceutical Co., Ltd

Address before: 250105 No. 849 Dong Jia town, Licheng District, Shandong, Ji'nan

Patentee before: QILU TIANHE PHARMACEUTICAL Co.,Ltd.